Clinical Trial Update: A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial comparing two Japanese encephalitis vaccines, ChimeriVax-JE and JE-VAX, has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• ChimeriVax-JE (live attenuated Japanese encephalitis vaccine)
• JE-VAX

Snippet

Sponsor: Sanofi | Conditions: Japanese Encephalitis | Phase 2 | Status: COMPLETED | Results posted: 2012-08-16